This $1,134,088.88 firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. to provide a Common Data Harmonization System FIDLE Integration. The contract has a period of performance through March 31, 2024 and is not set aside. Dnanexus, a for-profit organization, has a history of supporting FDA initiatives like the PrecisionFDA program, providing cloud-based bioinformatics tools and genomic analysis platform services to the regulatory...
This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
This federal contract award was granted by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit corporate entity based in Mountain View, California. The $6,755,725.98 Firm Fixed Price Delivery Order contract is for Dnanexus to provide the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists to enable collaboration on regulatory science and precision medicine...
Dnanexus, Inc. was awarded a firm fixed price delivery order valued at one hundred ninety-four thousand five hundred ninety-eight dollars and thirteen cents ($194,598.13) by the Department of Health and Human Services' Food and Drug Administration (FDA). This delivery order, with a period of performance through September 2023 and no set-aside designation, is issued against Dnanexus' twenty million dollar ($20M) indefinite delivery contract for ongoing provision of the FDA's PrecisionFDA...
This is a firm fixed-price delivery order contract awarded to Dnanexus, Inc. by the Food and Drug Administration (FDA) to provide operations and maintenance support for the agency's PrecisionFDA platform. The $4,073,921.12 contract has a period of performance through September 29, 2024 and does not have a set-aside designation. Dnanexus is a for-profit company that specializes in cloud-based genomics data management and analysis services. Through prior federal contracts, Dnanexus has supported...
Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...
The Department of Health and Human Services Food and Drug Administration awarded a $954,448.72 delivery order contract to Dnanexus, Inc., doing business as Dnanexus Inc., located in Mountain View, California. The contract period is from February 18, 2022 through February 21, 2023 and utilizes a firm fixed price contract type. Under the terms of the contract, Dnanexus Inc. will provide services to accept Real World Data through PrecisionFDA into the Food and Drug Administration's Intelligent...
This is a delivery order awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit technology company based in Mountain View, California. The contract, valued at $473,879.68, is for the operation and maintenance of the PrecisionFDA public instance of the Genomics Sequence and Regulatory Science (GSRS) platform. PrecisionFDA is a cloud-based genomics data management and analysis platform that enables collaboration between researchers and regulatory reviewers. This delivery...
This is a $1,051,402.26 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc. for the development of a PRISM high-impact platform pilot to support pre-submission validation of electronic common technical documents (eCTDs) and sponsor-reviewer interaction. The contract has an ultimate completion date of September 9, 2025. Dnanexus is a for-profit cloud-based genomics data management and analysis services provider that has previously supported the...
The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...